Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Mega International Commercial Bank



Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
The average size of a deal this fund participated in
Portfolio companies 3
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Banking
  • Financial Services
  • Payments
  • Transportation

Look at other 50 related and similar funds Collapse list
Fund NameLocation
7 Global Capital California, San Francisco, United States
AgTech Innovation Network -
Baize Capital Beijing, Beijing, China
Cockrell Investment Partners Houston, Texas, United States
Form Capital -
Honeywell International Morristown, New Jersey, United States
JT Venture Partners Burlington, Massachusetts, United States
Lauder Partners Atherton, California, United States
Novel Growth Partners Kansas, Overland Park, United States
Parinama Cultural Development Foundation -
Qunanda Zichan China, Guangdong, Shenzhen
RCM Business Bhilwara, India, Rajasthan
Shenzhen Qianhai Lichangrong Asset Investment Management -
SIOS Technology Corp. California, San Mateo, United States
Star Farm Ventures New York, New York, United States
Starr Companies New York, New York, United States
UCCVR China, Shanghai
Vang Capital England, London, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Elixiron Immunotherapeutics

$27M23 Aug 2021 New Taipei, Taiwan
Elixiron Immunotherapeutics Closes $27M Series A-1 Financing Round

– Elixiron Immunotherapeutics from San Francisco develops therapeutics for cancer, neurological diseases and inflammatory disorders.
– The company closed a $27m Series A-1 extension financing round.
– The round was jointly led by Pangu Capital (a new investor) and Taiwania Capital (an existing investor) and was joined by further new investors, including DCI Partners of Daiwa Securities Group, Mega International Commercial Bank, Fubon Financial Holdings and Hong Tai Electric Industrial, as well as other existing investors such as China Development Capital Industrial Bank (CDIB) Capital Group.
– The company intends to use the funds to advance phase 1 trials of two pipeline candidates and take three immuno-oncology assets towards IND applications.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Mega International Commercial Bank?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 188M
Peak activity year 2021
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Elixiron Immunotherapeutics

$27M23 Aug 2021 New Taipei, Taiwan
Crunchbase icon

Content report

The following text will be sent to our editors: